Loading…

Gamma knife management of skull base chordomas: Is it a choice?

Background: Skull base chordomas are locally invasive tumors which able to extend in different directions with skull base invasion. Although they are histologically benign, they have invasive nature makes total resection virtually impossible to achieve in most cases and this lead to residual tumors...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of neurosurgery 2018-10, Vol.13 (4), p.1037-1041
Main Authors: Zakaria, Wael, Hafez, Raef, Taha, Ahmed
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c446e-e19d6cf24a01916d2e4f1c08314c00c769ff711c6bc2908419f7875fa77868713
cites
container_end_page 1041
container_issue 4
container_start_page 1037
container_title Asian journal of neurosurgery
container_volume 13
creator Zakaria, Wael
Hafez, Raef
Taha, Ahmed
description Background: Skull base chordomas are locally invasive tumors which able to extend in different directions with skull base invasion. Although they are histologically benign, they have invasive nature makes total resection virtually impossible to achieve in most cases and this lead to residual tumors after surgery. To decrease postoperative surgical resection morbidity of these tumors, gamma knife radiosurgery (GKRS) was performed as alternative management for these residual chordomas to evaluate its safety and efficacy. Materials and Methods: A retrospective study was made on eight residual skull base chordomas treated with GKRS between 2011 and 2015. The mean patient age was 49 years (range 30–73 years). Four patients harboring chordoma were male, and four patients were females with 1:1 ratio. All patients had undergone one prior surgery. Patients were treated with peripheral dose ranged between 12–15 gray (Gy) (mean 13.75 Gy) usually at 35% to 50% isodose curve (mean 38.8%). The maximum dose to the adjacent brain stem area ranged between 10 and 12 Gy. All patients were followed up from 8 to 39 months (mean 18 months). Results: The tumor control rate was 50% and 25% after 18 and 36 months, respectively, but we found that their wasdeclined in the tumor control rate with long follow-up time. Four tumors were stable in their size just for 18 months, and then there two of these tumors were progressed in their size, the other four patients showed progression in their tumors in their 1 st year of treatment without sign of central tumor necrosis. Conclusion: Skull base chordoma patients complained from symptoms due to tumor mass effect which were not prospected to respond to GKRS alone as the aim of this type of treatment was the local tumor control, the tumor control rate declined with long follow-up time and this correlated with radioresistant nature of skull base chordoma. We advise a gross total resection to decrease the tumor volume, and this making gamma knife a reasonable treatment modality.
doi_str_mv 10.4103/ajns.AJNS_61_17
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6208200</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A559482605</galeid><sourcerecordid>A559482605</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446e-e19d6cf24a01916d2e4f1c08314c00c769ff711c6bc2908419f7875fa77868713</originalsourceid><addsrcrecordid>eNp1kk1vEzEQhlcIRKPSMze0EhLiktT2-mOXA1VU0VJUlQNwthzvOOvEa7f2LhH_vk7Tr0jUPlgeP_Nqxu8UxXuMZhSj6litfJrNf1z9khxLLF4VE0JoPW04pq-LCRZNNWW0JgfFUUorlBfDjCHytjioEGVNzatJcXKu-l6Va28NlL3yagk9-KEMpkzr0blyoRKUuguxDb1KX8qLVNqhVNuQ1XDyrnhjlEtwdH8eFn_Ovv0-_T69_Hl-cTq_nGpKOUwBNy3XhlCFcIN5S4AarFFdYaoR0oI3xgiMNV9o0qCa4saIWjCjhKh5LXB1WHzd6V6Pix5anWuMysnraHsV_8mgrNx_8baTy_BXcoJqglAW-HwvEMPNCGmQvU0anFMewpgkwRVnrEKYZ_TjDl0qB9J6E7Ki3uJyzliTv5QjlqnZf6i8W-itDh6MzfG9hE_PEjpQbuhScONgg0_74PEO1DGkFME8tomR3Dovt87LJ-dzxofnv_PIP_icgasdsAlugJjWbtxAlJld-7B5STfHKyHvJkTeTYh8mJCn7ofO5rtchTH6PAAvlngLbOnSPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2136553016</pqid></control><display><type>article</type><title>Gamma knife management of skull base chordomas: Is it a choice?</title><source>PubMed Central(OpenAccess)</source><creator>Zakaria, Wael ; Hafez, Raef ; Taha, Ahmed</creator><creatorcontrib>Zakaria, Wael ; Hafez, Raef ; Taha, Ahmed</creatorcontrib><description>Background: Skull base chordomas are locally invasive tumors which able to extend in different directions with skull base invasion. Although they are histologically benign, they have invasive nature makes total resection virtually impossible to achieve in most cases and this lead to residual tumors after surgery. To decrease postoperative surgical resection morbidity of these tumors, gamma knife radiosurgery (GKRS) was performed as alternative management for these residual chordomas to evaluate its safety and efficacy. Materials and Methods: A retrospective study was made on eight residual skull base chordomas treated with GKRS between 2011 and 2015. The mean patient age was 49 years (range 30–73 years). Four patients harboring chordoma were male, and four patients were females with 1:1 ratio. All patients had undergone one prior surgery. Patients were treated with peripheral dose ranged between 12–15 gray (Gy) (mean 13.75 Gy) usually at 35% to 50% isodose curve (mean 38.8%). The maximum dose to the adjacent brain stem area ranged between 10 and 12 Gy. All patients were followed up from 8 to 39 months (mean 18 months). Results: The tumor control rate was 50% and 25% after 18 and 36 months, respectively, but we found that their wasdeclined in the tumor control rate with long follow-up time. Four tumors were stable in their size just for 18 months, and then there two of these tumors were progressed in their size, the other four patients showed progression in their tumors in their 1 st year of treatment without sign of central tumor necrosis. Conclusion: Skull base chordoma patients complained from symptoms due to tumor mass effect which were not prospected to respond to GKRS alone as the aim of this type of treatment was the local tumor control, the tumor control rate declined with long follow-up time and this correlated with radioresistant nature of skull base chordoma. We advise a gross total resection to decrease the tumor volume, and this making gamma knife a reasonable treatment modality.</description><identifier>ISSN: 1793-5482</identifier><identifier>EISSN: 2248-9614</identifier><identifier>DOI: 10.4103/ajns.AJNS_61_17</identifier><identifier>PMID: 30459863</identifier><language>eng</language><publisher>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>Bone cancer ; Care and treatment ; Embryonal tumors ; Health aspects ; Methods ; Original ; Original Article ; Radiosurgery ; Skull base</subject><ispartof>Asian journal of neurosurgery, 2018-10, Vol.13 (4), p.1037-1041</ispartof><rights>Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon.</rights><rights>COPYRIGHT 2018 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright: © 2018 Asian Journal of Neurosurgery 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446e-e19d6cf24a01916d2e4f1c08314c00c769ff711c6bc2908419f7875fa77868713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208200/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208200/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30459863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zakaria, Wael</creatorcontrib><creatorcontrib>Hafez, Raef</creatorcontrib><creatorcontrib>Taha, Ahmed</creatorcontrib><title>Gamma knife management of skull base chordomas: Is it a choice?</title><title>Asian journal of neurosurgery</title><addtitle>Asian J Neurosurg</addtitle><description>Background: Skull base chordomas are locally invasive tumors which able to extend in different directions with skull base invasion. Although they are histologically benign, they have invasive nature makes total resection virtually impossible to achieve in most cases and this lead to residual tumors after surgery. To decrease postoperative surgical resection morbidity of these tumors, gamma knife radiosurgery (GKRS) was performed as alternative management for these residual chordomas to evaluate its safety and efficacy. Materials and Methods: A retrospective study was made on eight residual skull base chordomas treated with GKRS between 2011 and 2015. The mean patient age was 49 years (range 30–73 years). Four patients harboring chordoma were male, and four patients were females with 1:1 ratio. All patients had undergone one prior surgery. Patients were treated with peripheral dose ranged between 12–15 gray (Gy) (mean 13.75 Gy) usually at 35% to 50% isodose curve (mean 38.8%). The maximum dose to the adjacent brain stem area ranged between 10 and 12 Gy. All patients were followed up from 8 to 39 months (mean 18 months). Results: The tumor control rate was 50% and 25% after 18 and 36 months, respectively, but we found that their wasdeclined in the tumor control rate with long follow-up time. Four tumors were stable in their size just for 18 months, and then there two of these tumors were progressed in their size, the other four patients showed progression in their tumors in their 1 st year of treatment without sign of central tumor necrosis. Conclusion: Skull base chordoma patients complained from symptoms due to tumor mass effect which were not prospected to respond to GKRS alone as the aim of this type of treatment was the local tumor control, the tumor control rate declined with long follow-up time and this correlated with radioresistant nature of skull base chordoma. We advise a gross total resection to decrease the tumor volume, and this making gamma knife a reasonable treatment modality.</description><subject>Bone cancer</subject><subject>Care and treatment</subject><subject>Embryonal tumors</subject><subject>Health aspects</subject><subject>Methods</subject><subject>Original</subject><subject>Original Article</subject><subject>Radiosurgery</subject><subject>Skull base</subject><issn>1793-5482</issn><issn>2248-9614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><recordid>eNp1kk1vEzEQhlcIRKPSMze0EhLiktT2-mOXA1VU0VJUlQNwthzvOOvEa7f2LhH_vk7Tr0jUPlgeP_Nqxu8UxXuMZhSj6litfJrNf1z9khxLLF4VE0JoPW04pq-LCRZNNWW0JgfFUUorlBfDjCHytjioEGVNzatJcXKu-l6Va28NlL3yagk9-KEMpkzr0blyoRKUuguxDb1KX8qLVNqhVNuQ1XDyrnhjlEtwdH8eFn_Ovv0-_T69_Hl-cTq_nGpKOUwBNy3XhlCFcIN5S4AarFFdYaoR0oI3xgiMNV9o0qCa4saIWjCjhKh5LXB1WHzd6V6Pix5anWuMysnraHsV_8mgrNx_8baTy_BXcoJqglAW-HwvEMPNCGmQvU0anFMewpgkwRVnrEKYZ_TjDl0qB9J6E7Ki3uJyzliTv5QjlqnZf6i8W-itDh6MzfG9hE_PEjpQbuhScONgg0_74PEO1DGkFME8tomR3Dovt87LJ-dzxofnv_PIP_icgasdsAlugJjWbtxAlJld-7B5STfHKyHvJkTeTYh8mJCn7ofO5rtchTH6PAAvlngLbOnSPg</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Zakaria, Wael</creator><creator>Hafez, Raef</creator><creator>Taha, Ahmed</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>0U6</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181001</creationdate><title>Gamma knife management of skull base chordomas: Is it a choice?</title><author>Zakaria, Wael ; Hafez, Raef ; Taha, Ahmed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446e-e19d6cf24a01916d2e4f1c08314c00c769ff711c6bc2908419f7875fa77868713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Bone cancer</topic><topic>Care and treatment</topic><topic>Embryonal tumors</topic><topic>Health aspects</topic><topic>Methods</topic><topic>Original</topic><topic>Original Article</topic><topic>Radiosurgery</topic><topic>Skull base</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zakaria, Wael</creatorcontrib><creatorcontrib>Hafez, Raef</creatorcontrib><creatorcontrib>Taha, Ahmed</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Asian journal of neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zakaria, Wael</au><au>Hafez, Raef</au><au>Taha, Ahmed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma knife management of skull base chordomas: Is it a choice?</atitle><jtitle>Asian journal of neurosurgery</jtitle><addtitle>Asian J Neurosurg</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>13</volume><issue>4</issue><spage>1037</spage><epage>1041</epage><pages>1037-1041</pages><issn>1793-5482</issn><eissn>2248-9614</eissn><abstract>Background: Skull base chordomas are locally invasive tumors which able to extend in different directions with skull base invasion. Although they are histologically benign, they have invasive nature makes total resection virtually impossible to achieve in most cases and this lead to residual tumors after surgery. To decrease postoperative surgical resection morbidity of these tumors, gamma knife radiosurgery (GKRS) was performed as alternative management for these residual chordomas to evaluate its safety and efficacy. Materials and Methods: A retrospective study was made on eight residual skull base chordomas treated with GKRS between 2011 and 2015. The mean patient age was 49 years (range 30–73 years). Four patients harboring chordoma were male, and four patients were females with 1:1 ratio. All patients had undergone one prior surgery. Patients were treated with peripheral dose ranged between 12–15 gray (Gy) (mean 13.75 Gy) usually at 35% to 50% isodose curve (mean 38.8%). The maximum dose to the adjacent brain stem area ranged between 10 and 12 Gy. All patients were followed up from 8 to 39 months (mean 18 months). Results: The tumor control rate was 50% and 25% after 18 and 36 months, respectively, but we found that their wasdeclined in the tumor control rate with long follow-up time. Four tumors were stable in their size just for 18 months, and then there two of these tumors were progressed in their size, the other four patients showed progression in their tumors in their 1 st year of treatment without sign of central tumor necrosis. Conclusion: Skull base chordoma patients complained from symptoms due to tumor mass effect which were not prospected to respond to GKRS alone as the aim of this type of treatment was the local tumor control, the tumor control rate declined with long follow-up time and this correlated with radioresistant nature of skull base chordoma. We advise a gross total resection to decrease the tumor volume, and this making gamma knife a reasonable treatment modality.</abstract><cop>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India</cop><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><pmid>30459863</pmid><doi>10.4103/ajns.AJNS_61_17</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1793-5482
ispartof Asian journal of neurosurgery, 2018-10, Vol.13 (4), p.1037-1041
issn 1793-5482
2248-9614
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6208200
source PubMed Central(OpenAccess)
subjects Bone cancer
Care and treatment
Embryonal tumors
Health aspects
Methods
Original
Original Article
Radiosurgery
Skull base
title Gamma knife management of skull base chordomas: Is it a choice?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A39%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma%20knife%20management%20of%20skull%20base%20chordomas:%20Is%20it%20a%20choice?&rft.jtitle=Asian%20journal%20of%20neurosurgery&rft.au=Zakaria,%20Wael&rft.date=2018-10-01&rft.volume=13&rft.issue=4&rft.spage=1037&rft.epage=1041&rft.pages=1037-1041&rft.issn=1793-5482&rft.eissn=2248-9614&rft_id=info:doi/10.4103/ajns.AJNS_61_17&rft_dat=%3Cgale_pubme%3EA559482605%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c446e-e19d6cf24a01916d2e4f1c08314c00c769ff711c6bc2908419f7875fa77868713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2136553016&rft_id=info:pmid/30459863&rft_galeid=A559482605&rfr_iscdi=true